CoreBone
PrivateLast Round
Series A
Oct 4, 2021
Total Funding Raised
$4.04M
Company Overview
CoreBone is a health tech company that develops and manufactures bioactive, coral-based bone graft materials for dental and orthopedic applications.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Sustainable Materials, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CoreBone Comparables
Compare CoreBone with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zoan BioMed | 84% | |
| Marine Biomedical | 83% | |
| RevBio, Inc. | 80% | |
CoreBone Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 4, 2021 | ||||
| Crowdfunding | Dec 29, 2017 |
CoreBone Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Guangzhou Biotechnology Investment Fund | Series A |
| ExitValley | Crowdfunding |
| The Trendlines Group | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 4, 2021
$4M round led by Guangzhou Sino-Israel Biotech Investment Fund.
CoreBone Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CoreBone's valuation, stock price, and market status.